COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Retrospective Observational Safety Effectiveness With Kuvan in hpA (ROSEKA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03864029
Recruitment Status : Completed
First Posted : March 6, 2019
Last Update Posted : March 7, 2019
Quintiles, Inc.
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 9, 2018
Actual Study Completion Date : July 25, 2018